Columnists
Tipsheet
Cartoons
Podcasts
Newsletters
Sections
Podcasts
Townhall TV
Election
Capitol Voices
Entertainment
Radio News
Live Blog
Topics
Sites
Hot Air
PJ Media
Bearing Arms
Twitchy
RedState
JOIN VIP
LOGIN
MY ACCOUNT
Account Settings
Newsletter Subscriptions
Log Out
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Ase Industrial Holding Ltd ADR
(NY:
ASX
)
10.06
+0.11 (+1.11%)
Streaming Delayed Price
Updated: 3:50 PM EDT, Aug 19, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Press Releases about Ase Industrial Holding Ltd ADR
< Previous
1
2
3
4
Next >
Appendix 4C – Q4 FY24 Quarterly Cash Flow Report
July 31, 2024
From
ALTERITY THERAPEUTICS LIMITED
Via
GlobeNewswire
Global Uranium and Enrichment to Present at the OTCQB Venture Virtual Investor Conference August 1st
July 29, 2024
Global Uranium invites individual and institutional investors, as well as advisors and analysts, to attend in person or online at VirtualInvestorConferences.com
From
Virtual Investor Conferences
Via
GlobeNewswire
Alterity Therapeutics to Present at MST Financial Webinar
July 24, 2024
From
ALTERITY THERAPEUTICS LIMITED
Via
GlobeNewswire
Discover the Hidden Gem in Chip Manufacturing Stocks
July 24, 2024
ASE Technology Holding Co. Ltd. (NYSE: ASX) is a Taiwan-based semiconductor manufacturing company you’ve probably never heard of.
Via
MarketBeat
Topics
Artificial Intelligence
Exposures
Artificial Intelligence
Alterity Therapeutics Reports Positive Interim Data from ATH434-202 Phase 2 Clinical Trial in Multiple System Atrophy
July 17, 2024
From
ALTERITY THERAPEUTICS LIMITED
Via
GlobeNewswire
ISE Labs Expands Capabilities, Doubles Lab Space with Opening of Second Silicon Valley Location
July 11, 2024
From
Advanced Semiconductor Engineering, Inc.
Via
Business Wire
OTC Markets Group Welcomes Sovereign Metals Limited to OTCQX
July 05, 2024
From
OTC Markets
Via
GlobeNewswire
CSL Behring Announces First Two Patients Treated with HEMGENIX® (etranacogene dezaparvovec) Gene Therapy for Hemophilia B in Europe
July 04, 2024
From
CSL Behring
Via
GlobeNewswire
ASE Holdings Hosts Annual Supplier Day to Recognize Outstanding Suppliers of 2023
June 13, 2024
From
ASE Technology Holding Co., Ltd.
Via
Business Wire
Alterity Therapeutics to Present at the MST Access ‘Hidden Gems in Life Sciences’ Webinar
June 12, 2024
From
ALTERITY THERAPEUTICS LIMITED
Via
GlobeNewswire
Small-Cap Growth Virtual Investor Conference Agenda Announced for June 13th
June 11, 2024
Company Executives Share Vision and Answer Questions Live at VirtualInvestorConferences.com
From
Virtual Investor Conferences
Via
GlobeNewswire
Alterity Therapeutics to Host Webcast Today on New Data from the bioMUSE Natural History Study
May 29, 2024
From
ALTERITY THERAPEUTICS LIMITED
Via
GlobeNewswire
ASE Introduces powerSiP™ for Transformative Power Delivery That Increases Power Efficiencies by 50% in AI and Data Center Applications
May 29, 2024
From
Advanced Semiconductor Engineering, Inc.
Via
Business Wire
MatrixCare Joins Health Gorilla’s Qualified Health Information Network (QHIN) to Enhance Patient Data Access
May 16, 2024
The alliance with Health Gorilla will provide MatrixCare customers with more than 220 million patient records to streamline workflows and improve patient outcomes.
From
MatrixCare
Via
GlobeNewswire
OTC Markets Group Welcomes Neometals Ltd. to OTCQX
May 15, 2024
From
OTC Markets
Via
GlobeNewswire
Alterity Therapeutics Phase 2 Data Monitoring Committee Recommends Continuing Clinical Trial as Planned After Third Review
May 08, 2024
From
ALTERITY THERAPEUTICS LIMITED
Via
GlobeNewswire
Appendix 4C – Q3 FY24 Quarterly Cash Flow Report
April 30, 2024
From
ALTERITY THERAPEUTICS LIMITED
Via
GlobeNewswire
Alterity Therapeutics Presents New Data Demonstrating Potential of ATH434 to Treat Rare Neurodegenerative Disease Friedreich’s Ataxia
April 29, 2024
From
ALTERITY THERAPEUTICS LIMITED
Via
GlobeNewswire
Alterity Therapeutics Parkinson’s Disease and Multiple System Atrophy Data Featured at the American Academy of Neurology (AAN) 2024 Annual Meeting
April 17, 2024
From
ALTERITY THERAPEUTICS LIMITED
Via
GlobeNewswire
OTCQX Best 50 Virtual Investor Conference Agenda Announced for April 18th
April 15, 2024
Company Executives Share Vision and Answer Questions Live at VirtualInvestorConferences.com
From
Virtual Investor Conferences
Via
GlobeNewswire
Alterity Therapeutics to Present New Data on ATH434 at the World Orphan Drug Congress USA 2024
April 10, 2024
From
ALTERITY THERAPEUTICS LIMITED
Via
GlobeNewswire
Alterity Therapeutics Receives a A$3.9 Million Research & Development Tax Incentive Refund
March 26, 2024
From
ALTERITY THERAPEUTICS LIMITED
Via
GlobeNewswire
ASE’s VIPack™ Enables Innovational AI Devices Through Advanced Interconnect Technology for Chiplets
March 20, 2024
From
Advanced Semiconductor Engineering, Inc.
Via
Business Wire
NeoGames Announces Fourth Quarter and Full Year 2023 Results
March 06, 2024
From
NeoGames SA
Via
GlobeNewswire
Carnegie Clean Energy to Present at Clean/Renewable Energy Virtual Investor Conference February 22nd
February 22, 2024
Company invites individual and institutional investors, as well as advisors and analysts, to attend in person or online at VirtualInvestorConferences.com
From
Virtual Investor Conferences
Via
GlobeNewswire
Alterity Therapeutics to Present New Data at the Upcoming American Academy of Neurology 2024 Annual Meeting
February 20, 2024
From
ALTERITY THERAPEUTICS LIMITED
Via
GlobeNewswire
5 Semiconductor stocks under $10
February 16, 2024
Five semiconductor stocks priced under $10, each with buy ratings from analysts, offering intriguing opportunities in the world's hottest sector.
Via
MarketBeat
Topics
Artificial Intelligence
Earnings
Exposures
Artificial Intelligence
Financial
OTC Markets Group Welcomes Tolu Minerals Limited to OTCQX
February 12, 2024
From
OTC Markets
Via
GlobeNewswire
Alterity Therapeutics Phase 2 Data Monitoring Committee Recommends Continuing Clinical Trial as Planned After Second Review
February 06, 2024
From
ALTERITY THERAPEUTICS LIMITED
Via
GlobeNewswire
Battery & Precious Metals Virtual Investor Conference: Presentations Now Available for Online Viewing
February 02, 2024
Company Executives Share Vision and Answer Questions Live at VirtualInvestorConferences.com
From
Virtual Investor Conferences
Via
GlobeNewswire
< Previous
1
2
3
4
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.